181 related articles for article (PubMed ID: 8325891)
41. Osteopontin expression in the kidney during unilateral ureteral obstruction.
Kaneto H; Morrissey J; McCracken R; Reyes A; Klahr S
Miner Electrolyte Metab; 1998; 24(4):227-37. PubMed ID: 9554561
[TBL] [Abstract][Full Text] [Related]
42. Localization of osteopontin in the otoconial organs of adult rats.
Takemura T; Sakagami M; Nakase T; Kubo T; Kitamura Y; Nomura S
Hear Res; 1994 Sep; 79(1-2):99-104. PubMed ID: 7806488
[TBL] [Abstract][Full Text] [Related]
43. Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II.
Yu XQ; Wu LL; Huang XR; Yang N; Gilbert RE; Cooper ME; Johnson RJ; Lai KN; Lan HY
Kidney Int; 2000 Oct; 58(4):1469-80. PubMed ID: 11012882
[TBL] [Abstract][Full Text] [Related]
44. Osteopontin and calcium stone formation.
Kleinman JG; Wesson JA; Hughes J
Nephron Physiol; 2004; 98(2):p43-7. PubMed ID: 15499214
[TBL] [Abstract][Full Text] [Related]
45. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis.
Itoh Y; Yasui T; Okada A; Tozawa K; Hayashi Y; Kohri K
J Urol; 2005 Jan; 173(1):271-5. PubMed ID: 15592095
[TBL] [Abstract][Full Text] [Related]
46. Osteopontin expression in chronic pancreatitis.
Nakamura M; Oka M; Iizuka N; Kawauchi S; Gondo T; Ueno T; Tangoku A
Pancreas; 2002 Aug; 25(2):182-7. PubMed ID: 12142743
[TBL] [Abstract][Full Text] [Related]
47. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis.
Wüthrich RP; Fan X; Ritthaler T; Sibalic V; Yu DJ; Loffing J; Kaissling B
Autoimmunity; 1998; 28(3):139-50. PubMed ID: 9867126
[TBL] [Abstract][Full Text] [Related]
48. Role of inter-alpha-inhibitor and its related proteins in experimentally induced calcium oxalate urolithiasis. Localization of proteins and expression of bikunin gene in the rat kidney.
Atmani F; Glenton PA; Khan SR
Urol Res; 1999; 27(1):63-7. PubMed ID: 10092155
[TBL] [Abstract][Full Text] [Related]
49. Osteopontin regulation in cultured rat renal epithelial cells.
Malyankar UM; Almeida M; Johnson RJ; Pichler RH; Giachelli CM
Kidney Int; 1997 Jun; 51(6):1766-73. PubMed ID: 9186865
[TBL] [Abstract][Full Text] [Related]
50. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats.
Cowley BD; Ricardo SD; Nagao S; Diamond JR
Kidney Int; 2001 Dec; 60(6):2087-96. PubMed ID: 11737583
[TBL] [Abstract][Full Text] [Related]
51. Osteopontin antisense oligonucleotide inhibits adhesion of calcium oxalate crystals in Madin-Darby canine kidney cell.
Yamate T; Kohri K; Umekawa T; Iguchi M; Kurita T
J Urol; 1998 Oct; 160(4):1506-12. PubMed ID: 9751404
[TBL] [Abstract][Full Text] [Related]
52. Ultrastructural localization of osteopontin in the kidney: induction by lipopolysaccharide.
Madsen KM; Zhang L; Abu Shamat AR; Siegfried S; Cha JH
J Am Soc Nephrol; 1997 Jul; 8(7):1043-53. PubMed ID: 9219153
[TBL] [Abstract][Full Text] [Related]
53. Expression of osteopontin in cisplatin-induced tubular injury.
Iguchi S; Nishi S; Ikegame M; Hoshi K; Yoshizawa T; Kawashima H; Arakawa M; Ozawa H; Gejyo F
Nephron Exp Nephrol; 2004; 97(3):e96-105. PubMed ID: 15292680
[TBL] [Abstract][Full Text] [Related]
54. 1 alpha,25-dihydroxyvitamin D3 stimulation of osteopontin expression in rat clonal dental pulp cells.
Nagata T; Yokota M; Ohishi K; Nishikawa S; Shinohara H; Wakano Y; Ishida H
Arch Oral Biol; 1994 Sep; 39(9):775-82. PubMed ID: 7802613
[TBL] [Abstract][Full Text] [Related]
55. Differential regulation of osteopontin expression in the clipped and nonclipped kidney of two-kidney, one-clip hypertensive rats.
Gauer S; Hartner A; Hauser IA; Fierlbeck W; Eberhardt W; Geiger H
Am J Hypertens; 2003 Mar; 16(3):214-22. PubMed ID: 12620700
[TBL] [Abstract][Full Text] [Related]
56. De novo glomerular osteopontin expression in rat crescentic glomerulonephritis.
Lan HY; Yu XQ; Yang N; Nikolic-Paterson DJ; Mu W; Pichler R; Johnson RJ; Atkins RC
Kidney Int; 1998 Jan; 53(1):136-45. PubMed ID: 9453010
[TBL] [Abstract][Full Text] [Related]
57. Uropontin in urinary calcium stone formation.
Hoyer JR
Miner Electrolyte Metab; 1994; 20(6):385-92. PubMed ID: 7783701
[TBL] [Abstract][Full Text] [Related]
58. Quantitative analyses of osteopontin mRNA expression in human proximal tubules isolated from renal biopsy tissue sections of minimal change nephrotic syndrome and IgA glomerulonephropathy patients.
Kaimori JY; Takenaka M; Nagasawa Y; Nakajima H; Izumi M; Akagi Y; Imai E; Hori M
Am J Kidney Dis; 2002 May; 39(5):948-57. PubMed ID: 11979338
[TBL] [Abstract][Full Text] [Related]
59. Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR).
Giachelli C; Bae N; Lombardi D; Majesky M; Schwartz S
Biochem Biophys Res Commun; 1991 Jun; 177(2):867-73. PubMed ID: 1828666
[TBL] [Abstract][Full Text] [Related]
60. Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients.
Evan AP; Bledsoe S; Worcester EM; Coe FL; Lingeman JE; Bergsland KJ
Kidney Int; 2007 Dec; 72(12):1503-11. PubMed ID: 17898697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
